Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bungowannah Pestivirus Chimeras as Novel Double Marker Vaccine Strategy against Bovine Viral Diarrhea Virus.

Vaccines·2022
Same author

High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies.

PLoS pathogens·2021
Same author

Thermal Inactivation of Different Capripox Virus Isolates.

Microorganisms·2020
Same author

Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany.

Vaccines·2020
Same author

Establishment of a Challenge Model for Sheeppox Virus Infection.

Microorganisms·2020
Same author

Non-discriminatory Exclusion Testing as a Tool for the Early Detection of Foot-and-Mouth Disease Incursions.

Frontiers in veterinary science·2020

Related Experiment Video

Updated: Apr 1, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K

Chimeric Pestivirus Experimental Vaccines.

Ilona Reimann1, Sandra Blome2, Martin Beer1

  • 1Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Südufer 10, Greifswald, Insel Riems, 17493, Germany.

Methods in Molecular Biology (Clifton, N.J.)
|October 14, 2015
PubMed
Summary
This summary is machine-generated.

This study details the creation of a promising classical swine fever (CSF) vaccine candidate, CP7_E2alf. This chimeric pestivirus vaccine utilizes reverse genetics and cloning technologies for enhanced pestivirus infection control.

Keywords:
CP7_E2alfChimeric pestivirusCloningConstructionMarker vaccine candidateReverse genetics

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Related Experiment Videos

Last Updated: Apr 1, 2026

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

13.3K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

23.0K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Area of Science:

  • Veterinary Virology
  • Vaccine Development
  • Molecular Biology

Background:

  • Chimeric pestiviruses show promise as marker vaccines against pestiviral diseases.
  • Classical swine fever (CSF) remains a significant threat to swine populations globally.
  • Development of effective and safe CSF vaccines is crucial for disease control.

Purpose of the Study:

  • To describe the detailed construction and testing of a novel CSF vaccine candidate, CP7_E2alf.
  • To evaluate the potential of CP7_E2alf as a marker vaccine.
  • To showcase the application of classical cloning and reverse genetics in vaccine development.

Main Methods:

  • Construction of the chimeric pestivirus CP7_E2alf using classical cloning techniques.
  • Application of reverse genetics for viral genome manipulation and recovery.
  • In vitro and/or in vivo testing of the vaccine candidate (details not provided in abstract).

Main Results:

  • Successful construction and characterization of the CP7_E2alf vaccine candidate.
  • Demonstration of CP7_E2alf's potential as a marker vaccine against pestiviral infections.
  • Validation of cloning technologies and reverse genetics for generating pestivirus vaccines.

Conclusions:

  • CP7_E2alf represents a highly promising vaccine candidate for classical swine fever.
  • The study validates the use of chimeric pestiviruses and reverse genetics for developing effective pestivirus vaccines.
  • This approach offers a viable strategy for controlling pestiviral infections in swine.